T1	Participants 72 124	patients with malignant pleural mesothelioma (MS01):
T2	Participants 517 613	409 patients with malignant pleural mesothelioma, from 76 centres in the UK and two in Australia
T3	Participants 1351 1399	This study is registered, number ISRCTN54469112.
